Velan Capital Investment Management »

Verrica Pharmaceuticals shares owned by Velan Capital Investment Management

Quarter-by-quarter ownership of Verrica Pharmaceuticals (VRCA) shares owned by Velan Capital Investment Management from 13F filings

Historical chart of Velan Capital Investment Management investment in Verrica Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Verrica Pharmaceuticals held by Velan Capital Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verrica Pharmaceuticals by Velan Capital Investment Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.9M 472k 8.31

More positions owned by Velan Capital Investment Management

Praxis Precision Medicines I Com New (PRAX)
Cidara Therapeutics Com New (CDTX)
Protara Therapeutics Com Stk (TARA)
Heron Therapeutics (HRTX)
Maplight Therapeutics (MPLT)
Abivax Sa Sponsored Ads (ABVX)
Evommune Com Shs (EVMN)
Mineralys Therapeutics (MLYS)
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH)
Jasper Therapeutics Com New (JSPR)
Avalo Therapeutics Com New (AVTX)
Esperion Therapeutics (ESPR)
Verrica Pharmaceuticals Com Shs (VRCA)
Inspiremd (NSPR)
Rapt Therapeutics Com New (RAPT)

View all positions for Velan Capital Investment Management

Top funds holding Verrica Pharmaceuticals

Caligan Partners
Affinity Asset Advisors
Armistice Capital
Velan Capital Investment Management
Stonepine Capital Management
Boothbay Fund Management
DAFNA Capital Management
Vanguard Group
Jane Street
Marshall Wace
Millennium Management
Geode Capital Management
Squarepoint Ops
Sovran Advisors
Renaissance Technologies

View all funds holding Verrica Pharmaceuticals